Beyond ASSAIL-MI, the RESCUE study (NCT03926117; Trial to Evaluate Reduction in Inflammation in Patients with Advanced Chronic Renal Disease Utilizing Antibody-mediated IL-6 Inhibition) targeted IL-6 ligand in patients with chronic kidney disease at high risk for cardiovascular complications (10). Here, IL6 is linked to chronic kidney disease.